NCT07123675

Brief Summary

This study is being done to see if a new computer-based tool can help anesthesiologists keep patients' anesthesia levels more stable during surgery. Background: During general anesthesia, doctors carefully adjust medication doses to keep patients safely and comfortably unconscious. This requires constant attention. Researchers want to find out if a smart computer assistant can help with this task. Purpose of the Study: The main goal is to compare two ways of managing anesthesia. One way is the standard method used by doctors today. The other way is having the doctor use suggestions from a new computer program designed to recommend medication doses in real-time. We want to see if using the computer tool can lead to more stable anesthesia, potentially using less medication and helping patients recover more smoothly. Who Can Participate: The study will include adult patients who are scheduled to have surgery that requires general anesthesia. What Will Happen in the Study: If you choose to join, you will be randomly assigned (like flipping a coin) to one of two groups: Standard Care Group: Your anesthesiologist will manage your anesthesia medications based on their expert judgment and normal practice, as is done every day. Computer-Assisted Group: Your anesthesiologist will also manage your anesthesia, but they will see suggestions from a computer system on a screen. The doctor will always have the final say and can choose to follow or ignore the computer's advice to ensure your safety. In both groups, you will receive safe and complete anesthetic care. Your participation in the study will last for the duration of your surgery and the immediate recovery period. Researchers will look at information like the amount of medication used and how stable your anesthesia level was.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 14, 2025

Completed
18 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2025

Completed
Last Updated

August 14, 2025

Status Verified

August 1, 2025

Enrollment Period

3 months

First QC Date

August 8, 2025

Last Update Submit

August 8, 2025

Conditions

Keywords

Reinforcement LearningArtificial IntelligenceClinical Decision Support SystemDepth of Anesthesia

Outcome Measures

Primary Outcomes (1)

  • Mean Arterial Pressure Time in Range (MAP TIR)

    The percentage of time that the patient's Mean Arterial Pressure (MAP) is maintained within a pre-defined target range (e.g., 65-75 mmHg) during the surgical procedure. A higher percentage indicates more effective and stable blood pressure control.

    From the induction of anesthesia until the end of the surgical procedure.

Secondary Outcomes (4)

  • Variability of Mean Arterial Pressure (MAP)

    From the induction of anesthesia until the end of the surgical procedure.

  • Total Consumption of Propofol

    From the induction of anesthesia until the end of the surgical procedure.

  • Total Consumption of Remifentanil

    From the induction of anesthesia until the end of the surgical procedure.

  • Incidence of Intraoperative Adverse Events

    From the induction of anesthesia until the end of the surgical procedure.

Study Arms (2)

Experimental: AI-Assisted Anesthesia Management

EXPERIMENTAL

Participants in this arm will have their general anesthesia managed by an anesthesiologist with real-time guidance from an AI-based clinical decision support system. The system provides recommendations for drug administration and physiological parameter adjustments.

Device: Device: AI Clinical Decision Support System

Active Comparator: Standard Anesthesia Care

ACTIVE COMPARATOR

Participants in this arm will receive standard-of-care general anesthesia management. The anesthesiologist will make all clinical decisions based on their professional judgment and standard institutional practices, without the aid of the investigational AI system.

Procedure: Procedure: Standard of Care Anesthesia

Interventions

An AI-based software system that provides real-time, on-screen recommendations to the anesthesiologist regarding drug administration and adjustments to maintain optimal patient physiological parameter

Experimental: AI-Assisted Anesthesia Management

Standard anesthesia management according to institutional guidelines. The attending anesthesiologist makes all clinical decisions based on their expertise and judgment without input from the investigational AI system.

Active Comparator: Standard Anesthesia Care

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Age range: 18 to 85 years. 2. Patients undergoing non-cardiac surgery. 3. Receiving intravenous-inhalation combined general anesthesia with tracheal intubation during surgery.
  • \. Patients undergoing elective surgery. 5. Anesthesia maintenance plan includes:
  • Propofol for continuous sedation during the maintenance phase;
  • Remifentanil for continuous analgesia during the maintenance phase;
  • Sevoflurane or desflurane for inhalation anesthesia. 6. ASA physical status I-IV. 7. Continuous monitoring of blood pressure, heart rate, and Bispectral Index (BIS) during surgery.
  • \. Continuous invasive arterial blood pressure monitoring during surgery.

You may not qualify if:

  • \. Emergency surgery. 2. Continuous infusion of remifentanil or propofol for less than 30 minutes during surgery.
  • \. Receiving continuous intravenous sedatives other than propofol, or continuous infusion of intravenous sedatives other than propofol.
  • \. Receiving continuous intravenous analgesics other than remifentanil, or continuous infusion of intravenous analgesics other than remifentanil.
  • \. Inhaled anesthetic maintenance concentration is not equal to 0.5 Minimum Alveolar Concentration (MAC).
  • \. Allergy to propofol or allergic reaction to remifentanil. 7. Severe obesity (BMI ≥ 35 kg/m²).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Peking University People's Hospital

Beijing, Beijing Municipality, 100044, China

Location

Beijing Tsinghua Changgung Hospital

Beijing, Beijing Municipality, 102218, China

Location

Central Study Contacts

Gao Zhifeng, MD

CONTACT

Zheng Zhang, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The care provider (anesthesiologist) is not masked to the intervention, as they must be able to view and interact with the clinical decision support system in the experimental arm. The patient and the outcomes assessor will be masked.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Anesthesiology

Study Record Dates

First Submitted

August 8, 2025

First Posted

August 14, 2025

Study Start

September 1, 2025

Primary Completion

November 30, 2025

Study Completion

December 15, 2025

Last Updated

August 14, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations